NCT02635360 2025-07-03
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Phase 2 Completed
Clinical Trials
8 trialsNCT03527264 2025-04-04
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Brown University
Phase 2 Terminated
NCT05492123 2024-01-05
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
Hospital Israelita Albert Einstein
Phase 2 Recruiting
NCT05511623 2023-09-11
Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Recruiting
NCT05872724 2023-05-24
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Suzhou Municipal Hospital
Phase 2 Recruiting
NCT05311566 2022-04-13
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03963882 2019-06-20
NAC Followed by RH for the Treatment of LACC
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02309658 2015-10-16
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients
Professor Fernando Figueira Integral Medicine Institute
Phase 2 Completed